Inventor · disambiguated record
Yan Li
Also filed as: JONES STEVEN · LI YAN · LI YAN-RUIDE
38 granted patents·28 pending applications·682 citations·filing 1999–2025
98Inventor score
Files withALLERGAN INC9UNIV NORTH CAROLINA STATE8ASTERIAS BIOTHERAPEUTICS INC4UNIV SHANGHAI TECHNOLOGY4GENENTECH INC3
Top patents by PatentIndex Score
66 records- 0198US7422877B2Activatable recombinant neurotoxinsALLERGAN INC·Filed 2006·Granted Sep 9, 2008·88 cites·9 claims
- 0298US7419676B2Activatable recombinant neurotoxinsALLERGAN INC·Filed 2006·Granted Sep 2, 2008·131 cites·28 claims
- 0398US7132259B1Activatable recombinant neurotoxinsALLERGAN INC·Filed 2000·Granted Nov 7, 2006·158 cites·21 claims
- 0497US7709228B2Activatable recombinant neurotoxinsALLERGAN INC·Filed 2007·Granted May 4, 2010·53 cites·22 claims
- 0596US6911541B2Promoter fragment that is recognized by the product of the tobacco Nic geneUNIV NORTH CAROLINA STATE·Filed 2001·Granted Jun 28, 2005·45 cites·1 claims
- 0695US7959933B2Activatable recombinant neurotoxinsALLERGAN INC·Filed 2008·Granted Jun 14, 2011·24 cites·12 claims
- 0795US7455983B2Medium for growing human embryonic stem cellsGERON CORP·Filed 2004·Granted Nov 25, 2008·59 cites·1 claims
- 0892US10774136B2Anti-C5a binding moieties with high blocking activityINFLARX GMBH·Filed 2016·Granted Sep 15, 2020·5 cites·10 claims
- 0992US9458233B2Anti-C5a binding moieties with high blocking activityINFLARX GMBH·Filed 2015·Granted Oct 4, 2016·12 cites·28 claims
- 1092US7985411B2Activatable recombinant neurotoxinsALLERGAN INC·Filed 2008·Granted Jul 26, 2011·12 cites·26 claims
- 1190US8802096B2Anti-C5a binding antibodies with high block activityGUO RENFENG·Filed 2010·Granted Aug 12, 2014·22 cites·15 claims
- 1290US7192771B2Plant promoter sequenceUNIV NORTH CAROLINA STATE·Filed 2001·Granted Mar 20, 2007·14 cites·3 claims
- 1388US10676714B2Suspension culture of human embryonic stem cellsASTERIAS BIOTHERAPEUTICS INC·Filed 2018·Granted Jun 9, 2020·3 cites·11 claims
- 1487US12441983B2Suspension culture of human embryonic stem cellsASTERIAS BIOTHERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·21 claims
- 1587US9073983B2Anti-C5A binding moieties with high blocking activityINFLARX GMBH·Filed 2014·Granted Jul 7, 2015·13 cites·16 claims
- 1687US7994389B2Soybean genes for resistance to Aphis glycinesUNIV ILLINOIS·Filed 2005·Granted Aug 9, 2011·8 cites·7 claims
- 1781US9074181B2Suspension culture of human embryonic stem cellsMANDALAM RAMKUMAR·Filed 2006·Granted Jul 7, 2015·3 cites·7 claims
- 1881US2025244329A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 1980US10703775B2Method of purifying antifungal compounds and exopolysaccharides from a microbial cell cultureBAYER CROPSCIENCE LP·Filed 2017·Granted Jul 7, 2020·3 cites·13 claims
- 2078US2024288430A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2023·Application pending·0 cites
- 2177US12226424B2Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediatesUNIV SHANGHAI TECHNOLOGY·Filed 2019·Granted Feb 18, 2025·2 cites·17 claims
- 2277US11571446B2Gut microbiota and treatment of cancerSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2017·Granted Feb 7, 2023·1 cites·17 claims
- 2376US8119370B2Activatable recombinant neurotoxinsDOLLY J OLIVER·Filed 2008·Granted Feb 21, 2012·1 cites·14 claims
- 2476US7897744B2SARS virus nucleotide and amino acid sequences and uses thereofPUBLIC HEALTH AGENCY OF CANADA·Filed 2004·Granted Mar 1, 2011·9 cites·14 claims
- 2572US12329784B2Gut microbiota and treatment of cancerSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2023·Granted Jun 17, 2025·0 cites·15 claims
- 2671US7608273B2Recombinant lentivirus encoding modified GP 120 signal sequencesUNIV WESTERN ONTARIO·Filed 2005·Granted Oct 27, 2009·1 cites·13 claims
- 2770US8003351B2Activatable recombinant neurotoxinsALLERGAN INC·Filed 2008·Granted Aug 23, 2011·0 cites·24 claims
- 2870US2025064837A1Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediatesUNIV SHANGHAI TECHNOLOGY·Filed 2024·Application pending·0 cites
- 2969US2009030188A1Activatable recombinant neurotoxinsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3069US2020399592A1Suspension culture of human embryonic stem cellsASTERIAS BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3168US11576387B2Method for the preparation of bread by compounding natural yeastUNIV JIANGNAN·Filed 2019·Granted Feb 14, 2023·0 cites·8 claims
- 3267US8211671B2Activatable recombinant neurotoxinsDOLLY J OLIVER·Filed 2008·Granted Jul 3, 2012·0 cites·27 claims
- 3367US2008182294A1Activatable recombinant neurotoxinsALLERGAN INC·Filed 2007·Application pending·0 cites
- 3467US2006057723A1Transgenic plants containing molecular decoys that alter protein content thereinCONKLING MARK A·Filed 2004·Application pending·0 cites
- 3567US2024173356A1Extracellular Vesicles From Human Induced Pluroptent Stem CellsUNIV FLORIDA STATE RES FOUND·Filed 2023·Application pending·0 cites
- 3665US11674962B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2018·Granted Jun 13, 2023·0 cites·16 claims
- 3764US2006195936A1Methods and compositions for tobacco plants with reduced nicotineUNIV NORTH CAROLINA STATE·Filed 2006·Application pending·0 cites
- 3864US2007016975A1Methods and compositions for reduced putrescine methyl transferase and reduced quinolate phosphoribosyl transferase in plantsUNIV NORTH CAROLINA STATE·Filed 2006·Application pending·0 cites
- 3964US2006242730A1Methods and compositions for tobacco plants with reduced nitrosaminesUNIV NORTH CAROLINA STATE·Filed 2006·Application pending·0 cites
- 4064US2006191039A1Methods and compositions for protein production in tobacco plants with reduced nicotineUNIV NORTH CAROLINA STATE·Filed 2006·Application pending·0 cites
- 4163US2022117242A1Brown rice oat bread with low glycemic index and preparation method thereofUNIV JIANGNAN·Filed 2021·Application pending·0 cites
- 4263US2006236434A1Methods and compositions for tobacco plants with reduced nicotineUNIV NORTH CAROLINA STATE·Filed 2006·Application pending·0 cites
- 4362US11850215B2Recombinant adenoviruses and stem cells comprising sameGENEMEDICINE CO LTD·Filed 2018·Granted Dec 26, 2023·0 cites·8 claims
- 4461US7067134B1HIV vaccineUNIV WESTERN ONTARIO·Filed 1999·Granted Jun 27, 2006·15 cites·13 claims
- 4561US2005118154A1Antitumor effect of mutant BikFiled 2004·Application pending·0 cites
- 4661US2024287479A1Glycosyltransferase mutant, and method for catalytic synthesis of rebaudioside m using glycosyltransferase mutantXINGHUA GL STEVIA CO LTD·Filed 2022·Application pending·0 cites
- 4759US2025154539A1Recombinant microorganism for producing threonine and use thereofLANGFANG MEIHUA BIOTECHNOLOGY DEV CO LTD·Filed 2022·Application pending·0 cites
- 4859US2015307838A1Suspension Culture of Human Embryonic Stem CellsASTERIAS BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4958US2025122510A1Method for constructing threonine-producing engineered bacteriumLANGFANG MEIHUA BIOTECHNOLOGY DEV CO LTD·Filed 2022·Application pending·0 cites
- 5058US2023323302A1Combating covid-19 using engineered inkt cellsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yan Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →